Clinical Trial Update: An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease [Phase 2]

View source ↗

Summary

Australian Phase 2 trial evaluates mesenchymal stromal cells for Crohn's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mesenchymal Stromal Cell Therapy

Snippet

Sponsor: R.P.Herrmann | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED